517 results on '"Gueyffier F"'
Search Results
2. Pharmacokinetic/pharmacodynamic model of a methionine starvation based anti-cancer drug
3. Twice- or Once-Daily Dosing of Direct Oral Anticoagulants, a systematic review and meta-analysis
4. Impact of terminating reimbursement of symptomatic slow-acting drugs in osteoarthritis in France on volume and cost of drug deliveries, assessed with administrative databases
5. Association between difference in blood pressure reduction and risk of cardiovascular events in a type 2 diabetes population: A meta-regression analysis
6. MSR86 Use of Data Linkage for the Evaluation of Medical Devices: A Systematic Literature Review
7. Médicaments hypolipémiants
8. Preuves de bénéfice et décision thérapeutique : enquête auprès de médecins généralistes sur la prescription d’hydroxychloroquine pour traiter la Covid-19
9. Efficacy and safety of DPP-4 inhibitors in patients with type 2 diabetes: Meta-analysis of placebo-controlled randomized clinical trials
10. PROJET REBUILD THE EVIDENCE
11. How individual participant data meta-analyses have influenced trial design, conduct, and analysis
12. Is HbA1c a valid surrogate for macrovascular and microvascular complications in type 2 diabetes?
13. Tranexamic acid for epistaxis in hereditary hemorrhagic telangiectasia patients: a European cross‐over controlled trial in a rare disease
14. Effects of pharmacological treatments on micro- and macrovascular complications of type 2 diabetes: What is the level of evidence?
15. Endodontic versus coronal treatment quality on the periapical status
16. [OP.4A.03] PUBLIC HEALTH IMPACT OF CARDIOVASCULAR TREATMENTS IN PRIMARY PREVENTION: A SIMULATION STUDY ON A VIRTUAL REALISTIC POPULATION
17. [OP.3B.01] VALIDATION OF FRAMINGHAM AND SCORE IN 30560 PATIENTS WITH HYPERTENSION
18. [OP.1A.06] DOES DIABETES REALLY HARM WOMEN MORE THAN MEN? ANALYSES FROM 30560 INDIVIDUAL PATIENT DATA
19. Can we identify response markers to antihypertensive drugs? First results from the IDEAL Trial
20. Efficacy of a home-based intervention programme on the physical activity level and functional ability of older people using domestic services: A randomised study
21. Médicaments hypolipémiants
22. Les auteurs
23. Recueil systématique et actif des évènements indésirables médicamenteux chez les enfants admis aux urgences pédiatriques
24. KS02.4.A Olaparib in Recurrent IDH-mutant High-Grade Glioma (OLAGLI)
25. Quelques réflexions sur le double insu
26. Are we using blood pressure-lowering drugs appropriately? Perhaps now is the time for a change
27. Chapitre 23 - Médicaments hypolipémiants
28. Existe-t-il une surmortalité chez les femmes dépistées par mammographie? Méta-analyse sur la mortalité non liée au cancer du sein
29. TOWARDS EQUITABLE STRATEGIES FOR HYPERTENSION MANAGEMENT IN CARDIOVASCULAR PREVENTION: O4
30. Maintien de la rémission dans l’artérite à cellules géantes : comparaison indirecte des agents épargnant la corticothérapie par une revue systématique et une méta-analyse en réseau
31. Syndrome de Klinefelter, rôle du chromosome Y dans l’espérance de vie humaine ?
32. Dynamical modeling of pro- and anti-inflammatory cytokines in the early stage of septic shock
33. Efficacité antalgique d’une prise orale de paracétamol chez l’adulte en soins primaires pour traiter la douleur aiguë
34. Modelling and Clinical Trials in Paediatrics
35. Modélisation et essais cliniques en pédiatrie
36. Lisibilité de l’information écrite destinée aux sujets se prêtant à une recherche biomédicale: Une nécessaire remise en question
37. Safety of computerized drug management: a case report
38. Méthodologie des essais cliniques de petits effectifs
39. Methodology for Small Clinical Trials
40. Which, and How Limited Number of Polymorphisms Should Be Selected per Disease, Risk Assessment, Health Profile or Biological System?
41. Hypertension Optimal Treatment (HOT) trial
42. EFFICACY OF TREATING HYPERTENSION IN WOMEN: ASSESSMENT OF DIFFERENCES IN AGE AND RACE FOR CARDIOVASCULAR OUTCOMES
43. Comparison of bioprosthesis and mechanical valves, a meta-analysis of randomised clinical trials
44. Chapitre 23 - Médicaments hypolipémiants
45. Evaluation of the impact of terminating the reimbursement of a therapeutic class of drugs on the French health system: The example of symptomatic slow-acting drugs for osteoarthritis (SYSADOAs)
46. Effects of physical therapies aiming directly or indirectly at the recovery of balance after stroke. A meta-analysis
47. Effects of physical therapy on postural imbalance depending on time since stroke: A meta-analysis
48. L’interaction du sexe et du genre dans les essais contrôlés randomisés : une approche méta-épidémiologique
49. P034 Are patients with cystic fibrosis in clinical trials sensitive to the placebo effect? A metanalysis
50. Évaluation de l’impact du déremboursement d’une classe thérapeutique sur le système de santé français : l’exemple des anti-arthrosiques symptomatiques d’action lente (AASAL)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.